<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36841083</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5134</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Patient education and counseling</Title><ISOAbbreviation>Patient Educ Couns</ISOAbbreviation></Journal><ArticleTitle>A smartphone-based supportive counseling on health anxiety and acceptance of disability in Systemic Lupus Erythematosus patients: A randomized clinical trial.</ArticleTitle><Pagination><StartPage>107676</StartPage><MedlinePgn>107676</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pec.2023.107676</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0738-3991(23)00056-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aimed to evaluate the effects of a supportive counseling via the smart phone on the health anxiety, and acceptance of disability in the patients with Systemic Lupus Erythematosus.</AbstractText><AbstractText Label="METHODS">The present study was a randomized clinical trial with pre-post design. Randomly dividing 124 patients into experimental and control groups. Before and after the intervention, all patients answered the health anxiety and disability acceptance questionnaires. For eight weeks, the trial group received remote counseling help using the WhatsApp platform.</AbstractText><AbstractText Label="RESULTS">All 124 patients randomized into groups, completed follow-up which were analyzed. By the end of 8th week, the level of health anxiety (MD=11.34, P&#xa0;&lt;&#xa0;0.001) of the experiment group was significantly lower than the control group, while the level of acceptance of disability (MD=91.42, P&#xa0;&lt;&#xa0;0.001) of experiment group was significantly higher than the control group.</AbstractText><AbstractText Label="CONCLUSION">Smartphone-based supportive counseling may help people with Systemic Lupus Erythematosus manage their symptoms better, and live better by reducing health worry and increasing acceptance of impairment.</AbstractText><AbstractText Label="PRACTICE IMPLICATIONS">Virtual supportive counseling can assist healthcare professionals to optimize the potential of education and support processes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pasyar</LastName><ForeName>Nilofar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Community Based Psychiatric Care Research Center, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sam</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Student Research Committee,Nursing and Midwifery School, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivaz</LastName><ForeName>Mozhgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nursing, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: mrivaz2012@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazarinia</LastName><ForeName>Mohammadali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Patient Educ Couns</MedlineTA><NlmUniqueID>8406280</NlmUniqueID><ISSNLinking>0738-3991</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="Y">Smartphone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acceptance process</Keyword><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Counseling</Keyword><Keyword MajorTopicYN="N">Health</Keyword><Keyword MajorTopicYN="N">Lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Social media</Keyword><Keyword MajorTopicYN="N">Supporting information</Keyword><Keyword MajorTopicYN="N">Systemic</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest No competing interest was declared in the current study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>18</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36841083</ArticleId><ArticleId IdType="doi">10.1016/j.pec.2023.107676</ArticleId><ArticleId IdType="pii">S0738-3991(23)00056-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>